Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Monitoring Cytomegalovirus (HCMV) Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Using High-Performance miRNA Quantification Technology (PSTM-qPCR)

NCT07210242 is registered in ClinicalTrials.gov with Ting YANG as lead sponsor.

NCT NCT07210242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07210242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Monitoring Cytomegalovirus (HCMV) Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Using High-Performance miRNA Quantification Technology (PSTM-qPCR)
Lead sponsor
Ting YANG
Phase
Observational
Overall status
Not yet recruiting
Start date
October 10, 2025
Completion date
October 10, 2028
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections, graft vs host disease, hematopoietic stem cell transplantation, virus reactivation